CARBOPLATIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for carboplatin and what is the scope of freedom to operate?
Carboplatin
is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hikma, Hospira, Natco Pharma Usa, Pliva, Sandoz, Watson Labs Teva, Corden Pharma, Accord Hlthcare, Actavis Totowa, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Meitheal, Norvium Bioscience, Novast Labs, Pharmachemie Bv, Pliva Lachema, Sun Pharm, Teva Parenteral, Teva Pharms Usa, Teyro Labs, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.There are eighteen drug master file entries for carboplatin. Eleven suppliers are listed for this compound.
Summary for CARBOPLATIN
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 24 |
| NDAs: | 35 |
| Drug Master File Entries: | 18 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Clinical Trials: | 2,994 |
| Patent Applications: | 265 |
| Drug Prices: | Drug price trends for CARBOPLATIN |
| What excipients (inactive ingredients) are in CARBOPLATIN? | CARBOPLATIN excipients list |
| DailyMed Link: | CARBOPLATIN at DailyMed |
Recent Clinical Trials for CARBOPLATIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| EMD Serono | Phase 1 |
| Istituto Oncologico Veneto IRCCS | Phase 2 |
| Yale University | Phase 1 |
Pharmacology for CARBOPLATIN
| Drug Class | Platinum-based Drug |
Medical Subject Heading (MeSH) Categories for CARBOPLATIN
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPLATIN
US Patents and Regulatory Information for CARBOPLATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077139-002 | Sep 21, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cordenpharma | PARAPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 020452-002 | Jul 14, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Meitheal | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077096-004 | Jun 3, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Actavis Totowa | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 078732-001 | Feb 6, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gland Pharma Ltd | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 207324-003 | Feb 15, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Natco Pharma Usa | CARBOPLATIN | carboplatin | INJECTABLE;INJECTION | 091510-001 | May 29, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cordenpharma | PARAPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 020452-003 | Jul 14, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARBOPLATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Corden Pharma | PARAPLATIN | carboplatin | INJECTABLE;INJECTION | 019880-001 | Mar 3, 1989 | ⤷ Sign Up | ⤷ Sign Up |
| Cordenpharma | PARAPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 020452-001 | Jul 14, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Cordenpharma | PARAPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 020452-002 | Jul 14, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Cordenpharma | PARAPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 020452-004 | Jan 15, 2004 | ⤷ Sign Up | ⤷ Sign Up |
| Cordenpharma | PARAPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 020452-003 | Jul 14, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Corden Pharma | PARAPLATIN | carboplatin | INJECTABLE;INJECTION | 019880-003 | Mar 3, 1989 | ⤷ Sign Up | ⤷ Sign Up |
| Corden Pharma | PARAPLATIN | carboplatin | INJECTABLE;INJECTION | 019880-002 | Mar 3, 1989 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
